SPIE Conference Spotlights Imaging AI

- The global market for AI in medical imaging is projected to grow from $2.16 billion in 2026 to $8.23 billion by 2031, with North America holding the largest market share in 2025. This growth is driven by the rising volume of imaging data and the need to manage growing workloads, which is compounded by a persistent shortage of radiologists. - A significant trend is the shift of imaging services from hospitals to outpatient settings, with approximately 40% of all radiology procedures now conducted in these centers. This move is fueled by the potential for substantial cost savings—up to $125 billion annually in the U.S. healthcare system—and offers patients more convenient and affordable care. In response, many hospitals are developing their own freestanding imaging strategies or acquiring existing centers. - The U.S. is facing a critical and prolonged radiologist shortage, with demand for imaging expected to outpace the supply of radiologists through 2055. This is exacerbated by an aging workforce, with about 32% of radiologists aged 55 or older, and radiologist attrition rates having increased by 50% since 2020. - As of late 2025, the FDA had approved over 1,000 AI-enabled devices for radiology, which accounts for more than three-quarters of all such approvals in medicine. Leading vendors in terms of the number of cleared tools include GE HealthCare and Siemens Healthineers. - The 2026 Medicare Physician Fee Schedule is expected to continue a trend of reimbursement reductions for many imaging services due to a lower conversion factor, even as payments for specific procedures like CCTA are set to increase. Concurrently, the 2026 Hospital Outpatient Prospective Payment System (HOPPS) will see a 2.6% increase in its conversion factor. - AI tools are being developed to address workflow inefficiencies by automating tasks like recommending the correct imaging protocol, which can help reduce unnecessary scans. These systems can also assist in prioritizing urgent cases and highlighting abnormalities for radiologists. - Despite the rapid pace of innovation, the clinical adoption of AI in imaging faces hurdles, including the need for extensive validation, a lack of standardization in data and reporting, and challenges with integrating these new technologies into existing clinical workflows. Clinician trust and patient acceptance are also significant factors in the rate of adoption. - Mobile medical imaging is emerging as a strategic solution for health systems to expand their reach, improve patient access in underserved areas, and adapt to the shift toward outpatient care without the significant capital investment of a fixed site.